acrolein has been researched along with Group A Strep Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Hamid, MI; El-Mandrawy, SAM; Eldemery, F; Elnahriry, SS; Ibrahim, D; Ibrahim, SM; Khalifa, E; Metwally, AS | 1 |
| Faikoh, EN; Hong, YH; Hu, SY | 1 |
2 other study(ies) available for acrolein and Group A Strep Infection
| Article | Year |
|---|---|
Dietary cinnamaldehyde nanoemulsion boosts growth and transcriptomes of antioxidant and immune related genes to fight Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus).
Topics: Acrolein; Animal Feed; Animals; Antioxidants; Cichlids; Diet; Dietary Supplements; Disease Resistance; Dose-Response Relationship, Drug; Emulsions; Fish Diseases; Immunity, Innate; Nanostructures; Streptococcal Infections; Streptococcus agalactiae | 2021 |
Liposome-encapsulated cinnamaldehyde enhances zebrafish (Danio rerio) immunity and survival when challenged with Vibrio vulnificus and Streptococcus agalactiae.
Topics: Acrolein; Animals; Fish Diseases; Liposomes; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus agalactiae; Vibrio Infections; Vibrio vulnificus; Zebrafish | 2014 |